<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190803044417N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-09-06</date_registration>
      <primary_sponsor>The University of Urmia</primary_sponsor>
      <public_title>Effect of Brain Stimulation and Mindfulness in treatment of Epilepsy.</public_title>
      <acronym></acronym>
      <scientific_title>Comparing Effectiveness of Transcranial direct-current stimulation (tDCS) of Dorsa Lateral Prefrontal Cortex and Mindfulness-Based Cognitive Therapy (MBCT) On Frontal lobe performance and Psychological Profile in Patients with Epilepsy Disorder.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>45</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/41296</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: Forty five patients with epilepsy who were selected by convenience sampling and assigned randomly (At first, a list of available patients was prepared randomly and then coded from 01 to 45. Using random digits table, 15 person was assigned to each group.) to two experimental and one sham groups. Each group contains of 15 patients. For random assignment we used a lottery system. In the sham group, electrodes were connected but no stimulation was applied and participants were not aware of no stimulation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Temporal lobe Epilepsy.</hc_freetext>
      <i_freetext>Intervention 1: First intervention group: In first intervention group the tDCS applies for 20 min over the left  Dorso-lateral prefrontal cortex (DLPFC), the intensity is 1.5 mA. This method was applies in the first experimental group for 10 sessions. The first 5 sessions are consecutive, and the next 5 sessions are every other day. Based on the International 10–20 system, the anodal electrode will place in the F3 region of the left hemisphere, and the cathodal electrode will place in the F4 region of the right hemisphere. After 5 daily sessions, it is better to have the next 5 sessions every other day. Intervention 2: Second intervention group: In the second intervention group, Mindfulness-Based Cognitive Therapy (MBCT) is administered as an 8-week program. The class time include 2-2.5 h weekly. Participants encourage to complete daily home practice for 6 days per week. The duration of home sessions are about 45 min. Intervention 3: Control group: The sham group will receive no stimulation despite the electrodes being placed in and will not participate in the MBCT classes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Shahin Azmoodeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Literature and Humanities, Department of Psychology, Urmia University, Valfajr Blv, Seda va Sima St, Urmia, Iran</address>
        <city>Urmia</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5719848375</zip>
        <telephone>+98 914 118 0435</telephone>
        <email>shahin.azmoodeh@yahoo.com</email>
        <affiliation>The University of Urmia</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Shahin Azmoodeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Literature and Humanities, Department of Psychology, Urmia University, Valfajr Blv, Seda va Sima St, Urmia, Iran</address>
        <city>Urmia</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5719848375</zip>
        <telephone>+98 914 118 0435</telephone>
        <email>shahin.azmoodeh@yahoo.com</email>
        <affiliation>The University of Urmia</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Fill out the informed consent form
Having temporal lobe epilepsy
Age range between 15 to 50
At least be a middle school graduate
Not being pregnant
No prosthesis in the skull
No battery in the heart
Lack of psychological treatment in the past one year
No other medical illnesses such as skin disease, superficial injury and fracture or infraction of skull in the stimulation area</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Being pregnant
Prior Information about Sensitivity to tDCS
receiving psychological interventions and medications
Receiving medical interventions for any other disorder</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G40</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Epilepsy and recurrent seizures</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First intervention group: In first intervention group the tDCS applies for 20 min over the left  Dorso-lateral prefrontal cortex (DLPFC), the intensity is 1.5 mA. This method was applies in the first experimental group for 10 sessions. The first 5 sessions are consecutive, and the next 5 sessions are every other day. Based on the International 10–20 system, the anodal electrode will place in the F3 region of the left hemisphere, and the cathodal electrode will place in the F4 region of the right hemisphere. After 5 daily sessions, it is better to have the next 5 sessions every other day.</i_keyword>
      <i_keyword>Second intervention group: In the second intervention group, Mindfulness-Based Cognitive Therapy (MBCT) is administered as an 8-week program. The class time include 2-2.5 h weekly. Participants encourage to complete daily home practice for 6 days per week. The duration of home sessions are about 45 min.</i_keyword>
      <i_keyword>Control group: The sham group will receive no stimulation despite the electrodes being placed in and will not participate in the MBCT classes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Working memory. Timepoint: tDCS group: before intervention (pre-test) and 15 days later (post-test) ,MBCT group: before intervention (pre-test) and 8 weeks later (post-test) and in the sham group, the interval between pre-test and post-test was 15 days. Method of measurement: Wechsler Scale.</prim_outcome>
      <prim_outcome>Concentration. Timepoint: tDCS group: before intervention (pre-test) and 15 days later (post-test) ,MBCT group: before intervention (pre-test) and 8 weeks later (post-test) and in the sham group, the interval between pre-test and post-test was 15 days. Method of measurement: Continuous Performance Test.</prim_outcome>
      <prim_outcome>Attention. Timepoint: tDCS group: before intervention (pre-test) and 15 days later (post-test) ,MBCT group: before intervention (pre-test) and 8 weeks later (post-test) and in the sham group, the interval between pre-test and post-test was 15 days. Method of measurement: Stroop test.</prim_outcome>
      <prim_outcome>Cognitive Flexibility. Timepoint: tDCS group: before intervention (pre-test) and 15 days later (post-test) ,MBCT group: before intervention (pre-test) and 8 weeks later (post-test) and in the sham group, the interval between pre-test and post-test was 15 days. Method of measurement: Cognitive Flexibility Inventory.</prim_outcome>
      <prim_outcome>Psychological Profile. Timepoint: tDCS group: before intervention (pre-test) and 15 days later (post-test) ,MBCT group: before intervention (pre-test) and 8 weeks later (post-test) and in the sham group, the interval between pre-test and post-test was 15 days. Method of measurement: Depression Anxiety Stress Scales -21.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The University of Urmia</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-06-19</approval_date>
        <contact_name>Ethics committee of Urmia University of Medical Sciences</contact_name>
        <contact_address>No. 39, Entezar Ave., manzariye Street. Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
